More Gene Mutations Linked to Autism Risk
... - were found in the genes of children with autism
spectrum disorders (ASDs), but not in the healthy ... gene changes may contribute to an autism
spectrum disorder.
"We are finding that both ... are grateful to families of children with autism
spectrum disorders for their willingness to participate in ...
Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
... complex conditions such as those known as autism
spectrum disorders, researchers from different centers ... Hospital.
The consortium made autism
spectrum disorders the centerpiece of their meeting, said ... study to find a common gene involved in autism
spectrum disorders (ASDs), research that attracted ...
Autism Genes Discovered; Help Shape Connections Among Brain Cells
... .
Autism is the best known of the autism
spectrum disorders (ASDs), a group of childhood ... findings increase our understanding of how autism
spectrum disorders arise, and may in time foster the ... genetic variants on 5p14.1 associate with autism
spectrum disorders," Nature , published online April 28, ...
Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
... of mental retardation, birth defects, and autism
spectrum and developmental disorders now approved for use ... mental retardation, birth defects, and autism
spectrum and developmental disorders, which conventional ... anomalies, as well as in autism and autism
spectrum disorders.
In the U.S., the clinical ...
Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
... antibacterial, which
combines Novexel's broad
spectrum beta lactamase inhibitor, NXL104, with the
well ... a
novel, bactericidal injectable broad
spectrum cephalosporin. Ceftaroline is
being developed as ... than currently marketed inhibitors. Its
spectrum includes
class A (including ESBL and KPC) and ...
Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
... delafloxacin continues to show that this broad
spectrum compound is likely to be a valuable tool in the ... that has demonstrated activity against a broad
spectrum of bacteria, including quinolone-resistant ... an anionic fluoroquinolone active against a broad
spectrum of bacteria, including quinolone-resistant ...
Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
... which combines Novexel's broad
spectrum beta-lactamase
inhibitor, NXL104, with the well ... novel, bactericidal injectable broad
spectrum cephalosporin being
developed as a therapeutic ... marketed beta-lactam inhibitors. Its
spectrum includes class A
(including ESBL and KPC) and ...
Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
... progress in advancing this next-generation
broad
spectrum antibiotic further toward clinical use," said Dr. ... days.
About RX-3341
RX-3341 is a novel, broad
spectrum fluoroquinolone antibiotic which has
shown ... fluoroquinolone,
active against a broad
spectrum of bacteria, including
methicillin-resistant ...
Study Finds Fever may Lead to Improved Behavior in Children with Autism Spectrum Disorders
... and Physician
Reports that Children with Autism
spectrum Disorders Exhibit Fewer
Autistic-like Behaviors ... that the behaviors of children with
autism
spectrum disorders (ASD) tend to improve, sometimes ... basis of the disorder.
"Since autism
spectrum disorders are behaviorally defined and
diagnosed, ...
Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
... Paratek has designed two broad-
spectrum antibiotics that have
been shown to work against ... financing will allow Paratek to
bring our broad-
spectrum antibiotic into Phase 3 clinical studies, ... Paratek's lead compound, PTK
0796, is a broad
spectrum antibiotic derived from the tetracycline ...
Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference
... M.D., President and
Chief Executive Officer of
spectrum Pharmaceuticals, Inc. "We believe
SPI-1620 may ... doxorubicin and
5-FU in prostate tumor models.
spectrum has proprietary worldwide rights to SPI-1620. About
spectrum Pharmaceuticals ...
Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
... place in San Francisco
from October 13-17. The
spectrum trial results were presented on October
14. The ... Caldwell added, "Also, the results of the
spectrum trial are
important because it indicates that the ... or residual curarization. About the
spectrum trial(2) In this second profound block trial, ...
Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie
... as an intramuscular injection. In August
2004,
spectrum received an exclusive license from AEterna ... Canada and Mexico) and India. In addition,
spectrum will receive 50 percent of any upfront ... a key player in the Japanese oncology
market.
spectrum is developing ozarelix for benign prostatic ...
Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
... 73-4506 has been shown to inhibit tumor growth by hitting targets along a
spectrum of angiogenic pathways, including VEGFR and TIE2. BAY 73-4506 has also ... of these studies is not known and warrant further investigation in a broad
spectrum of tumors.
About Bayer HealthCare Pharmaceuticals Inc.
Bayer ...
Brain Waves Show Sound Processing Abnormalities in Autistic Children
... auditory and language processing may be evaluated in children with autism
spectrum disorder by using magnetoencephalography (MEG), according to a study ...
For the study, 64 patients, age six to 15, with a diagnosis of autism
spectrum disorder were evaluated with MEG. Audio stimulation was introduced to the ...
Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
... Infectious Disease: Overcoming Resistance and Extending the
Antimicrobial
spectrum of Macrolide Antibiotics." In his presentation on
August 3 and 4, Dr. ... program, a next
generation fluoroquinolone, active against a broad
spectrum of bacteria,
including methicillin-resistant Staphylococcus aureus. ...
BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
... 1,800 patients and volunteers, including data
from the SIGNAL, AURORA and
spectrum clinical trials. The SIGNAL trial
involved adult patients undergoing ... compared to 17.6 minutes in
the neostigmine/glycopyrrolate group.
The
spectrum trial was conducted in adult patients undergoing surgery
to study the ...
Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
... with two late-stage product candidates to address a broad
spectrum of obesity patients
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- ... currently developing two late-stage
product candidates to address the full
spectrum of obesity ranging from
mild-to-moderate and moderate-to-severe obesity. ...
Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
... in live animals using in vivo imaging technology.
Caliper's IVIS
spectrum was specifically chosen for its highly sensitive
luminescence detection ... .
Caliper and IVIS are registered trademarks, and
spectrum is a
trademark, of Caliper Life Sciences, Inc.
...
Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
... and other Gram-positive
organisms, RX-1741 has demonstrated both wider
spectrum and stronger
potency of activity than Zyvox(R) (linezolid), the only ... RX-3341 program, a next generation fluoroquinolone,
active against a broad
spectrum of bacteria, including
methicillin-resistant Staphylococcus aureus. ...
QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Women's Health Issues
... the capabilities of CMM
joint venture partners the Van Andel Institute and
spectrum Health.
"CMM is pleased that QIAGEN, a global leader in molecular ... for Molecular Medicine, a joint venture between Grand
Rapids, Mich.-based
spectrum Health and Van Andel Institute (VAI), brings
West Michigan a cutting-edge ...
Replidyne Provides Strategic Update
... their favorable safety and tolerability profiles, as well
as their broad
spectrum of activity, and as a result are often used as
first line therapy in many ... with increased mortality have occurred.
REP3123 is a new narrow
spectrum antibacterial agent that in vitro
prevents the growth of C. difficile by ...
VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
... testing of Lenocta has
demonstrated anti-tumor activity against a wide
spectrum of cancers.
About PTPases
The protein tyrosine phosphatase superfamily ... tyrosine kinases to control signaling
pathways that underlie a broad
spectrum of fundamental physiological
processes and represent a new class of ...
Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
... demonstrated that
oritavancin had potent in vitro activity against a wide
spectrum of
staphylococci likely to be encountered in a variety of clinical ... include:
-- In Vitro Activity Profile of Oritavancin against a Broad
spectrum of Aerobic and Anaerobic Bacterial Pathogens (E-1612, 12:15 p.m. CDT)
...
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
... in treating patients with complicated skin infections caused by a
broad
spectrum of bacteria. Ceftobiprole also was found to clinically cure
more than 90% ... intravenously every eight hours (1 g IV q8h) in
eradicating a broad
spectrum of Gram-positive and Gram-negative bacteria
associated with complicated ...
2,500 Cases Completed With the Magnetic Irrigated Catheter
... nearly 23,000 cases worldwide. These include ablations of a wide variety of cardiac arrhythmias in all four chambers of the heart and across a broad
spectrum of patients ranging from pediatric to geriatric. Included in the Niobe clinical experience are several very compelling procedures in patients with ...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
... researching and delivering pioneering medicines to patients with unmet medical needs. Amgen is studying denosumab in numerous tumor types across the
spectrum of cancer induced bone disease. Over 11,000 patients have been enrolled in the denosumab oncology clinical trials testing the drug for bone loss and ...
First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center
... eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader
spectrum of patients and their physicians. The Axxent treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal ...
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
... researching and delivering pioneering medicines to patients with unmet medical needs. Amgen is studying denosumab in numerous tumor types across the
spectrum of cancer induced bone disease. Over 11,000 patients have been enrolled in the denosumab oncology clinical trials testing the drug for bone loss and ...
EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
... Feed Additives segment. They range from amino
acids and antioxidants to flavors and colorants to probiotics and enzymes.
LAH also offers the entire
spectrum of vitamins and provitamins, including
beta-carotene, as well as specialties such as L-carnitine and botanicals.
For more information, please ...
When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research
...
However, the products are very different to other Maca based products and are not interchangeable, both due to the concentrated levels of the full
spectrum of active constituents, and multiple phenotypes. "Something a lot of people don't realize is that there are 13 different phenotypes within Maca, and ...
FDA Advisory Committee Votes in Favor of Zyprexa for Two Adolescent Indications
...
(11) Axelson D et al. (2006). Phenomenology of children and adolescents with bipolar
spectrum disorders. Archives of General Psychiatry; 63(10):1139-48.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
...
New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
... percent of Independents supporting investing more in prevention.
"This poll shows that Americans from coast to coast and across the political
spectrum are overwhelmingly in favor of investing in disease prevention," said Al Quinlan, President of Greenberg Quinlan Rosner Research. "More than ...
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
... and Infectious Diseases (ECCMID). The ECCMID conference is
taking place in Helsinki between 16th and 19th May 2009.
NXL104, Novexel's broad
spectrum class A and C beta-lactamase inhibitor,
is the subject of one poster. Novexel is currently conducting two Phase II
clinical trials in patients with ...
Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
... of antibiotics called macrocyclics, which inhibit the bacterial enzyme RNA polymerase, resulting in the death of Clostridium difficile . The narrow
spectrum profile of fidaxomicin may eradicate Clostridium difficile selectively with minimal disruption to the normal intestinal flora. This may facilitate ...
TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
... clinicians greater insight into the clinical utility of AIGIS."
"We are delighted these data indicate clinicians are using AIGIS in the full
spectrum of CRMD implant procedures. In particular, it is gratifying to see that AIGIS is being used in patients who are at very high risk for CRMD ...
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
...
"OXO(R) was built on the foundation of Universal Design, which focuses on creating easy and comfortable-to-use products for the widest
spectrum of users possible," said Alex Lee, President of OXO(R). "In partnering with UCB, we were able to apply our design principles in a new setting. The ...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
... will be available to us for research," says Dr. Henry Edelhauser, Ferst Professor at Emory University Eye Center. "This availability of a full
spectrum of human eye tissue will improve our understanding of the underlying events that lead to blindness. Even more importantly, what we learn will ...
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
... that will involve some 104 volunteers, with inoculation of the first groups expected to begin in mid-May.
"Initiation of this trial expands the
spectrum of malaria vaccines in clinical development today," said Dr. Christian Loucq, Director of MVI. "This trial marks a major achievement in a ...
Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
... of antibiotics called macrocyclics, which inhibit the bacterial enzyme RNA polymerase, resulting in the death of Clostridium difficile . The narrow
spectrum profile of fidaxomicin may eradicate Clostridium difficile selectively with minimal disruption to the normal intestinal flora. This may facilitate ...